Senior insider sale
President & CEO at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$135.6K
8.04K shares
What this filing means
BRYNJELSEN SEAN plans to sell 8.04K shares of ETON PHARMACEUTICALS, INC. valued at approximately $135.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001974078-25-000478
DirectorOfficer· President & CEO
Since Nov 2018
8.04K
Shares to sell
$135.6K
Approx. market value
8.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Grant
Grant
12/11/2025
8.04KTotal acquired8.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2025 | Grant Grant | 8.04K | — |
| Total | 8.04K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.04K
Market value
$135.6K
12/12/2025
Total
Units
8.04K
Value
$135.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2025 | 8.04K | $135.6K | NASDAQ | Planned |
| Total | 8.04K | $135.6K | ||